Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VXUS vs MRNA✓SelectedUSD · MRNAVXUS vs MRNA performance historyLatest closeAs of-2.00%11/16
Stock and ETF performance explorer

VXUS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+110.7%
MRNA return
+878.5%
Excess return
-767.8%
Maximum drawdown
-34.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.0%-3.6%+1.6%-1.9%
7D-2.7%-20.0%+17.3%-2.0%
30D-2.9%-1.3%-1.7%-3.0%
3M-7.5%+240.0%-247.5%-13.4%
6M-1.9%+339.0%-340.9%-9.8%
YTD+8.1%+630.0%-621.8%-3.3%
1Y+10.9%+769.1%-758.2%-1.8%
3Y+61.0%+181.2%-120.2%+47.6%
5Y+43.5%-8.1%+51.6%+34.2%
All+110.7%+878.5%-767.8%+89.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling